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Multiple patterns of 11/3-hydroxysteroid dehydrogenase
catalytic activity along the mammalian nephron
SABINE KENOUCH, NATHALIE COUTRY, NICOLETTE FARMAN, and JEAN-PIERRE BONVALET
INSERM U246, Faculte de Médecine X. Bichat, Paris, France
Multiple patterns of 11-hydroxysteroid dehydrogenase along the
mammalian nephron. The enzyme 1 1f3-hydroxysteroid dehydrogenase
(1 l/3-OHSD) is thought to be a protective enzyme of the mineralocor-
ticoid receptor (MR). We have previously demonstrated (Bonvalet et al,
J Cli,, Invest 86:832—837, 1990) that 11/.3-OHSD is colocalized with MR
along the rabbit nephron. In the present study, we examined whether
1 l/3-OHSD is similarly located along the nephron of other mammals.
Various tubular segments were microdissected from the mouse, rat, and
rabbit nephron, and incubated for two hours at 37°C in the presence of
11 nM [3H]-corticosterone (B). Thereafter, the respective amounts of B
and [3H]-l idehydrocorticosterone (A) in the incubation solution were
measured by HPLC. In the rabbit, the mouse and the rat, about 520
pmol/10 mm of B were transformed into A in tubular segments
possessing MR, that is, the distal parts of the nephron (distal and
collecting tubule). Differences appeared in the aldosterone-insensitive
proximal tubule; in both the initial and final parts of this segment,
1113-OHSD activity was low (26 pmol/lO mm) in the rabbit and the
mouse, and relatively high in the rat (328 pmol/l0 mm). In the cortical
part of the loop of Henle, where the presence of MR is still under
discussion, I 113-OHSD activity was low in the mouse (70 pmolllo mm),
high in the rat (533 pmolllo mm) and intermediate in the rabbit (227
pmol/lO mm). The comparison of these results with previous data
obtained with immunohistochemical methods suggests that the proxi-
mal and distal nephron might express different isoforms of I 1/3-OHSD.
The enzyme 1 1/3-hydroxysteroid dehydrogenase (1 1f3-
OHSD) is considered as a key enzyme for tissue sensitivity for
aldosterone [1, 2]. Since, in vitro, aldosterone and glucocorti-
coids bind to the mineralocorticoid receptor (MR) with the
same affinity [1], the large physiological excess of glucocorti-
coids over aldosterone prevailing in vivo should lead to a
permanent occupancy of the MR by glucocorticoids, in the
absence of cellular mechanism(s) responsible for a selective
binding of aldosterone to MR. The enzyme 11 /3-OHSD has been
shown to degrade natural glucocorticoids (cortisol and corticos-
terone) into 1 1-dehydro metabolites with low affinity for the MR
[1], which keeps the MR free for aldosterone binding and
action. A defect in this enzyme activity, either congenital [3—61
or acquired [7—10], leads to a syndrome of apparent mm-
eralocorticoid excess, including severe arterial hypertension
and hypokalemia in the absence of elevated plasma aldosterone
concentration.
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To firmly assign 1lJ3-OHSD as a "protective" enzyme for the
MR, it is necessary to clearly establish that this enzyme is
specifically localized in aldosterone-sensitive cells possessing
MR. At the present time, contrasting results have been re-
ported. In the rabbit, high 1 1/3-OHSD activity was found in the
aldosterone-sensitive cells of the cortical collecting tubule
(CCD). This was demonstrated either in freshly dissected
tubules [11] or in primary cultures of immunoselected CCD
cells [12]. This high activity contrasts with low levels observed
all along the proximal tubule [11]. An inverse localization has
been reported in the rat using immunohistochemical methods.
With a polyclonal antibody against the rat hepatic 1 113-OHSD,
Edwards et al [21 and Rundle et al [13] immunolocalized the
enzyme in the proximal straight tubule, without any staining in
the CCD. Castello et al [14] found a similar result with an
antibody directed against the rat renal 1 1/3-OHSD. Further-
more, a high enzyme activity was detected in both proximal and
distal-enriched rat tubular suspensions [21. In the mouse, Hier-
hoizer et a! [151 reported a high I 1I3-OHSD activity in lyophi-
lized proximal tubules.
These discrepancies may originate from different technical
approaches. Alternatively, they may reflect actual species
differences. To examine this point, the conversion rate of
[3H]-corticosterone was measured by HPLC all along the
nephron of the mouse, the rat and the rabbit.
Results show that in these three species a high 11f3-OHSD
activity is present in the aldosterone-sensitive cells of the distal
nephron. By contrast, the level of 1 1f3-OHSD activity in the
aldosterone-insensitive tubular segments differs according to
the species. In particular, whereas it is very low in the proximal
tubule of the mouse and the rabbit, high values (although lower
than in the distal nephron) are present in the proximal tubule of
the rat.
Methods
Experiments were performed in female mice (Swiss OS1, 18
to 20 g body wt), rats (Wistar, 150 to 180 g body wt) and rabbits
(New Zealand, 1.0 to 1.2 kg body wt). Animals were fed a
standard diet and had free access to tap water up to time of the
experiment. Rabbits were killed by a blow behind the neck.
Mice were anesthetized with ether. Rats received Pentobarbital
(5.0 mg/lOO g body wt i.p.). Immediately after, the abdominal
aorta of rats and mice was catheterized. For rabbits, a catheter
was inserted into the left renal artery. Kidneys were perfused
Kenouch et a!: 1113-OHSD along mammalian nephron 57
with an ice cold solution containing (in millimolar concentra-
tion) NaC1, 137; KCI, 5; MgSO4, 0.8; Na2HPO4, 0.33; KH2PO4,
0.44; MgCI2, 1; CaCI2, 1; D-glucose, 5; and Tris-HCI, 10; pH
7.4, followed by perfusion of a collagenase solution [similar
solution to which 0.1% collagenase (Serva, Heidelberg, 0.71
U/mg) was added].
Isolation of tubular segments
Microdissection was performed as previously described [16].
Thin pyramid pieces of the kidney (including cortex and me-
dulla) were cut and incubated in the same collagenase solution
for one hour at 30°C. Microdissection was performed at 4°C in
4 ml of microdissection solution [similar to the incubation
solution except for the absence of collagenase and the addition
of 0.1% BSA (Sigma Chemical Co., St. Louis, Missouri, USA)].
The duration of the microdissection period was about one
hour. The following segments were isolated: proximal tubules
in their initial (proximal convoluted tubule: PCT) or final parts
(pars recta: PR); thick ascending limb of the loop of Henle, in
their medullary (mTAL) or cortical (cTAL) parts; collecting
tubules in their cortical (CCD) or outer medullary (OMCD)
parts. The early distal convoluted tubule (DCT) was dissected
only from mouse kidney.
Incubation of tubular segments with [3H]-corticosterone
Pools of 10 mm of tubular segments were incubated with
[3H]-corticosterone. For this purpose, tubules were transferred
with 1 d mierodissection solution into Eppendorf tubes con-
taining 5 .d of the same solution added with 13 nM l-2-[3H]-
corticosterone (Amersham, G.B, SA: 1.68 TBq/mmol). Tubes
were incubated for two hours at 37°C, In some tubes, 1 LM of
the cofactor NADP (Sigma Chemical Co.) or 0.8 mM carbenox-
olone (CBX, Sigma), an inhibitor of the I lf3-OHSD were added
to the incubation solution. This concentration of CBX is higher
than that used in other studies [12, 17], and may affect other
enzymatic systems [18]. However, we have chosen it because
we previously showed [11] that it results in an almost complete
inhibition of 1 1/3-OHSD. Furthermore the present study was
limited to measurement of 1 l/3-OHSD catalytic activity in vitro,
without examination of eventual involvement of CBX in cell
functions. The incubation was stopped by adding 100 tl of a
19% acetonitrile solution (mobile phase) and by freezing tubes
at —20°C.
HPLC analysis
HPLC analysis was performed as previously described [11].
A CN reverse-phase column (tBondapak CN, Waters Associ-
ates, Milford, Massachusetts, USA) with a precolumn (Cl8, 5
tm, Société Francaise de Chromatographie, Paris, France) was
used. The incubation solution containing tubules was centri-
fuged at 8,000 g for 5 minutes (Sigma 202-MC, Osterode,
Germany). To have internal standards, 5 g unlabeled corticos-
terone and 5 tg unlabeled 1 1-dehydro-L-corticosterone (both
from Sigma Chemical Co.) were added to 100 d supernatant of
tubular samples. Samples were injected onto the column and
eluted isocratically with the mobile phase, 2 mI/mm, with the
elution profile monitored by absorbance at 240 nm (Beckman
Gold HPLC System, Beckman Instruments, Gagny, France).
Fractions of 1 ml were collected every 30 seconds (Retriever
III; Isco, Lincoln, Nebraska, USA) in counting vials containing
5 ml of scintillation fluid (Optiphase; Packard Instruments,
Downers Grove, Illinois, USA) for 25 minutes. The radioactiv-
ity was counted in a liquid scintillation counter (Rackbeta; LKB
Instruments, Inc, Gaithersburg, Maryland, USA).
Results are expressed as pmol of 1 l-dehydrocorticosterone
formed per 10 mm tubules and per two hours of incubation. It
should be noticed that, in our experimental conditions, high
rates of corticosterone conversion in some tubular segments
(see Fig. 1, CCD) lead to a substrate depletion at the end of the
incubation. This may result in an underestimation of the differ-
ences between absolute values in tubular segments with high
enzyme activity as compared to those with low activity.
Results
Figure 1 shows examples of the HPLC profiles obtained in
PCT and CCD of the mouse nephron. It appears clearly that
almost all [3H]-corticosterone (B) was transformed into [3H]-
dehydro-L-corticosterone (A) in the CCD, whereas only a small
amount of A was detected in the PCT, In both tubular types,
carbenoxolone 0.8 mM, an inhibitor of llf3-OHSD, drastically
reduced the conversion of B to A. The mean values of II-
dehydrocorticosterone formed by the various tubular segments
of the mouse tubule are shown in Figure 2. The conversion rate
of B into A was low (26 to 94 pmol/l0 mm) from the proximal
convoluted tubule up to the end of the thick ascending limb of
the Henle's loop. By contrast, very high values (475 to 575
pmol/10 mm) were yielded in the distal parts of the nephron,
that is, the early distal convoluted tubule and the collecting duct
in its cortical and medullary parts. Carbenoxolone reduced the
conversion rate to very low values in the proximal convoluted
tubule, the cortical part of the thick ascending limb, and the
cortical collecting duct.
The rate of [3H1-B conversion along the rat nephron is
illustrated in Figure 3. As in the mouse nephron, a very high
enzyme activity was observed in the cortical and medullary
parts of the collecting duct. Due to the difficulty in dissecting
early distal convoluted tubules in this species, l1/3-OHSD
activity was not measured in this tubular segment. Clear
differences with the mouse were observed along the proximal
tubule and the loop of Henle. A high rate of conversion (259 to
328 pmol/lO mm) was present in both parts of the rat proximal
tubule. Although lower than in the collecting tubule, they
largely exceeded those of the corresponding tubular segments
of the mouse. Another clearcut difference between rat and
mouse was observed in the cortical part of the thick ascending
limb. In the rat, the conversion rate was as high as in the
collecting duct (533 pmolIlO mm), contrasting with the mouse
where it was low (70 pmol/l0 mm), comparable to those in the
proximal tubule. This difference was not observed in the mTAL
where low values were present in both species. The inhibitory
effect of carbenoxolone was almost complete, as in the mouse.
In order to compare directly the present results to our
previously published data [11] in the rabbit, additional experi-
ments were done in this species. The conversion rate of
corticosterone was determined on samples of ten millimeters
length, as in the rat and the mouse, instead of 50 millimeters in
our previous experiments. Conversion rate was 530 pmol/lO
mm (N = 2) in the cortical collecting tubule, a value close to
that measured in rat and mouse. In the proximal tubule, a low
rate of conversion (14 pmol/l0 mm, N = 2) was present that was
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Fig. 2. Distribution of !1/3-hydroxysteroid dehydrogenase along the
mouse nephron. [3H]-1 1-dehydrocorticosterone formed during the in-
cubation is expressed as pmol/l0 mm tubular length. Mean values are
given with SE. Numbers of tubular samples (10 mm each) are indicated
under columns. Black columns correspond to results in the presence of
carbenoxolone (CBX, 0.8 mM). Abbreviations are: PCT, proximal convo-
luted tubule; PR, pars recta; mTAL and cTAL, medullary and cortical
parts of the thick ascending limb; DCT, early distal convoluted tubule;





25Fig. 1. Conversion of [3H]-corticosterone (B)
to 13H1-11-dehydrocorticosterone (A) by
proximal convoluted tubule (PCT) and cortical
collecting tubule (CCD) of the mouse. Tubular
samples were incubated for two hours at 37°C
in 5 d of a solution containing B (II nM) in
the absence (top) or presence (bottom) of
carbenoxolone (CBX, 0.8 mM). At the end of
the incubation, 100 pi mobile phase (19 %
acetonitrile) were added and the tubes were
centrifuged. Unlabeled corticosterone and 11-
dehydrocorticosterone were added to the
supernatant. Samples were injected onto CN
reverse-phase column and eluted isocratically,
2 mI/mm, with control of the elution profile at
240 nm. Black and white arrows indicate the
peak of unlabeled B and A, respectively, as
25 determined by UV detection. Fractions were
collected every 30 seconds. Counts per
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Fig. 3. Distribution of / 113-hydroxysteroid dehydrogenase along the
rat nephron. [3H]-l 1-dehydrocorticosterone formed during the incuba-
tion is expressed as pmol/10 mm tubular length. Mean values are given
with SE. Numbers of tubular samples (10 mm each) are indicated under
columns. Black columns correspond to results in the presence of
carbenoxolone (CBX, 0.8 mM). Abbreviations are: PCT, proximal
convoluted tubule; PR, pars recta; mTAL and cTAL, medullary and
cortical parts of the thick ascending limb; CCD and OMCD, cortical and
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close to that of the mouse, and clearly differed from that of the
rat. In the rabbit cTAL, the conversion rate was 229 27
pmol/10 mm (N = 5), a value intermediate between those of the
rat and mouse. Since large interspecies differences in I 113-
OHSD activity were present in the cortical thick ascending
limb, we wondered whether a gradual variation of l1p-OHSD
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activity could take place along this structure. In such a case, the
observed differences could be related to the fact that isolated
cTAL were taken at variable distances from the macula densa;
to test this hypothesis, cTAL were dissected on their entire
length from mouse kidney. Then, the isolated segments were
cut into two parts, and the enzyme activity was measured either
in the more superficial (close to the macula densa) part, or in the
deepest part. Mean values did not differ (64 6 pmol!l0 mm,
N = 5 and 75 22 pmol/l0 mm, N = 6, respectively), indicating
that no axial variation in enzyme activity occurs along the
cTAL, at least in the mouse.
We have previously shown [11] in the rabbit, that, in intact
cells of isolated tubule, the low enzyme activity in some
segments cannot be accounted for by the absence of the
cofactor NADP in the incubation solution. We checked this
observation again by measuring the conversion rate of [3H]-
corticosterone in two tubular segments with low enzyme activ-
ity (proximal convoluted tubule and cortical thick ascending
limb from the rabbit and the mouse) in the presence of NADP
l0_6 M. In this condition, the conversion rate in the proximal
tubule was 74 pmol/l0 mm in the mouse and 45 pmol/l0 mm in
the rabbit. For the cTAL, it was 130 pmol/ 10 mm in the mouse
and 229 pmol/l0 mm in the rabbit (N = 2 in each case).
Although these values were somewhat higher than those in the
absence of NADP (except for the rabbit thick ascending limb)
they remain much lower than those of the distal nephron.
Discussion
The present results clearly demonstrate that a high level of
conversion of corticosterone into 1 1-dehydrocorticosterone in
the distal parts of the nephron is a common feature of the three
mammalian species. This finding is in agreement with previous
data reported by our group on 11 /3-OHSD activity along the
rabbit renal tubule [11], and with those of Edwards et al [2] on
rat renal tubular suspensions. The characterization of this
enzyme activity has been recently performed by Naray-Fejes-
Toth et al in primary cultures of rabbit immunoselected CCD
cells [121. Concerning the mouse, Hierhoizer et al [15] found
that the enzyme activity, determined on lyophilized tubules in
the presence of 100 nM corticosterone, was higher in the
proximal than in the collecting tubule. However, when these
authors utilized low concentrations (I nM) of corticosterone on
intact tubules, they found results close to ours, that is a much
higher 11 13-OHSD activity in the distal than in the proximal
parts of the renal tubule.
This high 1 l/3-OHSD activity in the distal nephron of several
species has to be related to a bulk of evidence establishing the
distal nephron, and particularly the collecting tubule, as a major
site of aldosterone binding and action. High aldosterone binding
has been repeatedly reported in these tubular segments [16, 19,
201, and MR has been immunolocalized all along the distal
nephron, using a monoclonal antiidiotypic antibody against MR
[211. The stimulation of sodium reabsorption, potassium and
proton excretion, and Na-K-ATPase activity by aldosterone
in these structures is well established [reviewed in 221. Thus,
the colocalization of high 1 lf3-OHSD activity with MR in cells
where aldosterone effects are well documented is compatible
with the notion of a protective effect of MR by this enzyme, and
constitutes a solid argument in favor of this hypothesis.
The situation differs in other tubular segments, such as the
cTAL and the proximal tubule. In the cTAL, ll/3-OHSD
activity was low in the mouse (rate of conversion 70 12
pmol/l0 mm), high in the rat (533 17 pmol/lO mm) and
intermediate in the rabbit (229 27 pmol/l0 mm). The presence
and level of aldosterone binding in the cortical thick ascending
limb is not established with certainty. The existence of [3H]-
aldosterone binding in isolated cortical thick ascending limb
was detected [231 or not detected [16, 19] in the rabbit, and was
found at a low level in the rat [24]. Thus, at the present time, no
clear relationship can be established between the presence of
ll/3-OHSD activity and of MR in this segment.
In the proximal tubule of the rat and the rabbit, neither MR
nor aldosterone action have been evidenced [16, 22]. The low
level of ll/3-OHSD, the protective enzyme for the MR, is thus
not surprising in these aldosterone- insensitive cells. This is the
case in the proximal tubule of the rabbit and the mouse. This
low activity cannot be ascribed to the lack of the cofactor
NADP in the incubation solution, since we [11, and present
results] and Monder et al [17] showed that the addition of this
cofactor does not significantly modify the 1 113-OHSD activity in
intact isolated tubules.
Surprisingly, a high I 1f3-OHSD activity was detected in the
proximal tubule of the rat, in accordance with previous findings
of Edwards et al [21 on tubular suspensions of rat renal tubules.
In addition, immunohistochemical methods, performed with a
polyclonal antibody against ll/3-OHSD of the rat hepatic [2, 13]
or renal [14] enzyme, revealed an immunostaining in the prox-
imal tubule of the rat, associated with the absence of staining in
the cortical collecting tubule.
A possible explanation of these results would be that the
enzyme recognized by this antibody differs from the distal MR
protective enzyme. Indeed, recent studies indicate that several
isoforms of the enzyme may exist at the mRNA [25, 26] and
protein [27] level in the rat kidney. In addition, Stewart et al [28]
have recently performed in situ hybridization of llp-OHSD
mRNA in rat kidney tissue: I 1j3-OHSD mRNA was expressed
in both proximal and cortical collecting tubules, a finding in
accordance with the present results, and contrasting with
previous immunohistochemical data [2, 13, 14]. As a hypothe-
sis, it can be suggested that one isoform with high affinity for
glucocorticoids predominates in aldosterone-sensitive cells;
this form might not be detectable by immunostaining, and its
role could be to protect the MR from basal circulating levels of
glucocorticoids. Another isoform, with a lower affinity for
glucocorticoids, could be prominent in aldosterone-insensitive
cells and detectable by immunohistochemistry; its putative role
could be to buffer huge increases in plasma glucocorticoid
concentration, as can be induced by stress.
Consistent with this hypothesis, Hierholzer et al [15] reported
different localizations of 11/3-OHSD activity along the mouse
tubule, according to corticosterone concentration. At low con-
centration (1 nM), conversion of corticosterone into 1 1-dehy-
drocorticosterone occurred mainly in the aldosterone-sensitive
collecting tubule, whereas at high concentration (100 nM) it
largely predominated in the final part of the aldosterone-
insensitive proximal tubule. Such an observation could be
compatible with the presence of large amounts of an isoform
with low affinity in the proximal tubule (as evidenced by
immunohistochemistry) and of smaller amounts of an isoform
with high affinity in the collecting tubule. The reason(s) for the
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interspecies variations in llp-OHSD activity in the aldoster-
one-insensitive proximal tubule cells is yet not known, and
necessitates further study.
In conclusion, we demonstrate that, in three mammals, a high
ll3-OHSD activity is localized in aldosterone-sensitive cells of
the distal nephron. Species differences appear in aldosterone-
insensitive cells of the proximal tubule: 11 /3-OHSD activity is
low in the mouse and rabbit, and high in the rat. Together with
data on immunolocalization of the enzyme, our results are
compatible with the hypothesis that different isoforms of the
enzyme could be localized in the aldosterone-insensitive prox-
imal cells and in the aldosterone-sensitive distal cells.
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